Literature DB >> 28569045

A novel EWS-CREB3L3 gene fusion in a mesenteric sclerosing epithelioid fibrosarcoma.

Barbara Dewaele1, Louis Libbrecht2, Gabriel Levy3, Benedicte Brichard3, Vanessa Vanspauwen1, Raf Sciot4, Maria Debiec-Rychter1.   

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) is a rare, malignant fibroblastic neoplasm, morphologically composed of cords, nests or sheets of monotonous epithelioid cells within a collagenous matrix. It has been recently characterized by recurrent pathogenic EWS-CREB3L1/2 or FUS-CREB3L2 fusions and common MUC4 protein expression by immunohistochemistry. Typically SEF occur in middle-aged adults and rarely have been reported within the abdominal cavity. Here we report an 18-year-old man with intraabdominal tumor and multiple disseminated liver metastases, presenting pure SEF histologic and immunophenotypic features. Fluorescence in situ hybridization analysis showed unbalanced rearrangement of Ewing sarcoma breakpoint region 1 (EWSR1) gene. Genomic profiling by array CGH, followed by RT-PCR and sequencing analysis, revealed a previously not reported EWSR1 translocation partner, cAMP-responsive element-binding protein 3-like 3 (CREB3L3). The novel EWSR1-CREB3L3 fusion further extends the range of fusion types involving EWSR1 that are characteristic for SEF.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28569045     DOI: 10.1002/gcc.22474

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

Review 1.  What's new in fibroblastic tumors?

Authors:  Susan M Armstrong; Elizabeth G Demicco
Journal:  Virchows Arch       Date:  2019-12-11       Impact factor: 4.064

Review 2.  Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature.

Authors:  Yusuke Tsuda; Brendan C Dickson; Sarah M Dry; Noah Federman; Albert J H Suurmeijer; David Swanson; Yun-Shao Sung; Lei Zhang; John H Healey; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2019-11-15       Impact factor: 5.006

3.  Clinical utility of custom-designed NGS panel testing in pediatric tumors.

Authors:  Lea F Surrey; Suzanne P MacFarland; Fengqi Chang; Kajia Cao; Komal S Rathi; Gozde T Akgumus; Daniel Gallo; Fumin Lin; Adam Gleason; Pichai Raman; Richard Aplenc; Rochelle Bagatell; Jane Minturn; Yael Mosse; Mariarita Santi; Sarah K Tasian; Angela J Waanders; Mahdi Sarmady; John M Maris; Stephen P Hunger; Marilyn M Li
Journal:  Genome Med       Date:  2019-05-28       Impact factor: 11.117

4.  Sclerosing Epithelioid Fibrosarcoma of the Thoracic Vertebrae: An Fairly Unusual Case Report With a Short Review of Literature.

Authors:  Changhong Wei; Yili Ma; Dengqiang Wu; Xiaoyu Chen; Chunjun Li; Jun Chen; Sufang Zhou
Journal:  Front Med (Lausanne)       Date:  2022-06-28

5.  A case of cellular variants of Sclerosing epithelioid fibrosarcoma resembling Plasmacytoma/Myeloma: Diagnostic difficulty in the fine needle aspiration.

Authors:  Nahoko Nagano; Noriyoshi Ishikawa; Mamiko Nagase; Asuka Araki; Teruaki Iwahashi; Riruke Maruyama
Journal:  Int J Surg Case Rep       Date:  2020-03-07

Review 6.  Metastatic pediatric sclerosing epithelioid fibrosarcoma.

Authors:  Andrew D Woods; Charles Keller; Aman Wadhwa; Reshma Purohit; Laura Crocker Mitchell; John R Collier; Katherine A Collier; Melvin Lathara; Katrina Learned; Olena Vaske; Heather Geiger; Kazimierz O Wrzeszczynski; Vaidehi Jobanputra; Ganapati Srinivasa; Erin R Rudzinski; Kimberly Whelan; Elizabeth Beierle; Sheri L Spunt
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.